Local view for "http://purl.org/linkedpolitics/eu/plenary/2000-07-05-Speech-3-261"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech²
dcterms:Date	"2000-07-05"^^xsd:date²
dcterms:Is Part Of	lp_eu:Proposal for a regulation on a Community patent²
dcterms:Language	"en"^^xsd:language²
lpv:document identification number	"en.20000705.8.3-261"²
lpv:hasSubsequent	lp_eu:2000-07-05-Speech-3-262²
lpv:speaker	lp:John Purvis²
lpv:spoken text	"We welcome the fact that this is going to be a great spur to innovation and development and the competitiveness of European industry in the future if it does get through the IGC and onto the statute book. Following up Mrs Fraisse's question and your response to that, the borderline must be established as to what is acceptable for patenting and what is not. In the biotechnology area there is still this grey area. You purported to have reached an absolute decision on this. Is there any room for manoeuvre or is that the absolutely determined and settled position of the Commission as you said in your earlier answer?"@en¹
lpv:spokenAs	member; EPP-ED (1999-07-20--2004-07-19)³ unknown; Scottish Conservative and Unionist Party (1999-07-20--2004-07-19)³ substitute; Delegation to the EU-Bulgaria Joint Parliamentary Committee (1999-10-08--2002-01-14)³ substitute; ECON (1999-07-21--2002-01-14)³ member; Delegation for relations with the Mashreq countries and the Gulf (1999-10-06--2002-01-14)³ member; Committee on Industry, External Trade, Research and Energy (1999-07-21--2002-01-14)³
lpv:unclassifiedMetadata	"Purvis (PPE-DE )."¹

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph